Instrument Inactif

Communiqués Inspyr Therapeutics Inc OTC Bulletin Board

Actions

Recherche biotechnologique et médicale

Cours en clôture OTC Bulletin Board
- ^USD	-

21/08/23	Rebus Holdings, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023	CI
15/05/23	Rebus Holdings, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2023	CI

Communiqués

31/03/23	REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
21/11/22	NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
16/11/22	REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
13/10/22	REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
12/08/22	Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	PU
12/08/22	NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
13/05/22	NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
31/03/22	REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
12/11/21	NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
12/10/21	Inspyr Therapeutics : Material Event - Form 8-K/A	PU
12/10/21	INSPYR THERAPEUTICS : Form 8-K	PU
12/10/21	INSPYR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
05/10/21	Inspyr Therapeutics : AGREEMENT AND PLAN OF MERGER (Form 8-K)	PU
05/10/21	INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
16/08/21	Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
21/06/21	Inspyr Therapeutics : SENIOR CONVERTIBLE DEBENTURE DUE JUNE 18, 2022 (Form 8-K)	PU
21/06/21	INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
17/05/21	Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
31/03/21	INSPYR THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
12/01/21	INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
27/11/20	INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
20/11/20	Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	AQ
29/10/20	INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
08/10/20	INSPYR THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
27/08/20	Inspyr Therapeutics : President Trump Authorizes Plasma Treatment	AQ